SALTARELLA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.411
AS - Asia 1.554
EU - Europa 1.341
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 313
AF - Africa 93
OC - Oceania 2
Totale 7.095
Nazione #
US - Stati Uniti d'America 3.320
SG - Singapore 616
IT - Italia 472
CN - Cina 308
BR - Brasile 298
RU - Federazione Russa 197
SE - Svezia 153
HK - Hong Kong 152
VN - Vietnam 145
DE - Germania 111
FR - Francia 100
BD - Bangladesh 88
FI - Finlandia 85
GB - Regno Unito 72
IN - India 51
ID - Indonesia 47
CA - Canada 44
BE - Belgio 30
ZA - Sudafrica 26
AR - Argentina 24
CI - Costa d'Avorio 24
PL - Polonia 23
MX - Messico 22
IQ - Iraq 19
CO - Colombia 18
TR - Turchia 18
MA - Marocco 17
JP - Giappone 16
LT - Lituania 16
ES - Italia 14
VE - Venezuela 14
NL - Olanda 12
PH - Filippine 11
SA - Arabia Saudita 11
AT - Austria 10
JO - Giordania 10
EC - Ecuador 9
UA - Ucraina 9
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
PK - Pakistan 7
IE - Irlanda 6
MY - Malesia 6
AZ - Azerbaigian 5
JM - Giamaica 5
CH - Svizzera 4
CL - Cile 4
IR - Iran 4
KE - Kenya 4
RO - Romania 4
UY - Uruguay 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
AU - Australia 2
BY - Bielorussia 2
CG - Congo 2
CY - Cipro 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
HT - Haiti 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BG - Bulgaria 1
CU - Cuba 1
CV - Capo Verde 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
Totale 6.770
Città #
Ashburn 480
Singapore 356
San Jose 281
Fairfield 229
Chandler 219
Hong Kong 149
Woodbridge 148
Beijing 146
Nyköping 129
Council Bluffs 116
Seattle 116
Cambridge 106
New York 106
Ann Arbor 104
Milan 104
Houston 103
Wilmington 102
Los Angeles 96
Bari 77
Helsinki 67
Lauterbourg 51
Dallas 50
Rome 49
Ho Chi Minh City 45
Santa Clara 41
Munich 37
Jakarta 36
Brooklyn 34
São Paulo 32
Roxbury 31
Lawrence 30
Brussels 29
Columbus 29
Hanoi 26
Nanjing 25
Abidjan 24
Dong Ket 23
Falkenstein 22
Chicago 21
Buffalo 20
Frankfurt am Main 20
Moscow 20
Boardman 19
London 19
Phoenix 18
Des Moines 17
Johannesburg 17
Tokyo 16
San Diego 15
Washington 15
Dearborn 14
Montreal 14
Orem 14
Stockholm 14
Grottaglie 13
Marseille 13
The Dalles 13
Toronto 13
Warsaw 13
Denver 12
Inglewood 12
Salvador 12
Chennai 11
Turku 11
Amman 10
Atlanta 10
Curitiba 10
Rio de Janeiro 10
Turin 10
Paris 9
Princeton 9
Baghdad 8
Florence 8
Jacksonville 8
Manchester 8
Mexico City 8
Nuremberg 8
Poplar 8
Vienna 8
Basingstoke 7
Brasília 7
Figino 7
Guangzhou 7
Haiphong 7
Jiaxing 7
Bogotá 6
Boston 6
Dublin 6
San Francisco 6
Secaucus 6
Sorocaba 6
Tashkent 6
Ankara 5
Cincinnati 5
Erbil 5
Medellín 5
Naples 5
Palermo 5
Riyadh 5
Venice 5
Totale 4.500
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 229
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 221
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 194
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 192
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 188
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 186
Identify multiple myeloma stem cells: Utopia? 186
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 185
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 171
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 169
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 168
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 161
Bortezomib treatment modulates autophagy in multiple myeloma 161
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 160
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 156
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 155
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 151
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 149
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 144
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 143
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 142
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 141
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 135
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 134
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 134
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 132
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 131
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 129
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 125
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 124
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 118
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 112
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 110
Drug repurposing in skeletal muscle ion channelopathies 108
Antiangiogenic drugs as chemosensitizers in hematological tumors 104
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 103
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 103
null 101
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 96
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 96
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 91
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 89
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 89
Pharmacological therapy of non-dystrophic myotonias 89
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 88
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 87
The “angiogenic switch” from MGUS to MM: what about the Notch role? 84
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 83
Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies? 80
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 74
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 74
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 70
NSAIDS AS MODULATORS OF CATION CHANNELS: FENAMATES REPURPOSING IN CHANNELOPATHIES 64
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 58
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 51
null 31
null 30
RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cells 16
Totale 7.095
Categoria #
all - tutte 28.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022241 0 0 3 11 9 18 18 16 23 22 40 81
2022/2023560 52 89 45 44 51 70 11 74 84 11 15 14
2023/2024305 15 34 18 23 48 114 8 7 5 7 8 18
2024/20251.318 47 24 63 64 90 115 239 156 48 67 155 250
2025/20263.023 394 124 170 265 333 200 348 87 371 289 135 307
2026/2027282 111 97 74 0 0 0 0 0 0 0 0 0
Totale 7.095